Articles tagged with Randomization
A randomized trial found that physicians who received periodic letters recommending evidence-based drug therapy were more likely to prescribe those drugs. The study, which involved 499 physicians in British Columbia, showed a 30% increase in prescribing of recommended drugs over the preceding 3 months.
A randomized trial of adult stem cell injections in heart failure patients showed significant improvement in cardiac function. The study found that patients who received stem cells had improved ejection fractions and increased Connexin 43 protein levels, indicating better communication between cells.
A study of premenopausal women with abnormal uterine bleeding found that hysterectomy improved health-related quality of life within six months compared to expanded medical treatment. Another study in Finland compared the LNG-IUS to hysterectomy for menorrhagia, finding similar outcomes and lower costs for the intrauterine system.
A study found that early treatment with thrombolytics can significantly improve stroke recovery rates, with patients treated within 90 minutes of symptom onset showing the most improvement. The study also suggests that t-PA given up to 4 hours after symptoms may be beneficial, but the effect diminishes later.
A study of 332 randomized trials found industry-funded trials more likely to yield statistically significant pro-industry findings. Pharmaceutical companies prioritize trials with higher potential for positive results. This bias affects not only medical treatments but also new surgical interventions.
A study found that half of parents did not understand randomization, with minority and less-educated parents being more likely to be confused. However, the presence of a nurse and longer conference duration were associated with improved understanding.
A randomized controlled trial suggests that modest exercise, such as 30 minutes of daily walking, can not only prevent weight gain but also lead to additional loss of weight and fat. The study found a dose-response effect between the amount of exercise and decreases in measurements of central obesity and total body fat mass.
The study found that adding rituximab to the CHOP regimen as a first-line treatment did not significantly impact overall response rates or early disease progression. Maintenance rituximab showed promise in prolonging time-to-treatment failure, but had no effect on overall survival.
A randomized controlled trial found no evidence that Echinacea purpurea is effective in reducing the duration or severity of upper respiratory tract infections (URIs) in children aged 2-11 years. The study also noted a higher risk of rashes in children treated with echinacea.
A recent meta-analysis has found that vitamin E and beta carotene supplements do not reduce the risk of cardiovascular disease or death. The analysis analyzed data from seven trials involving over 1000 participants, concluding that these supplements may even increase mortality rates.
A new study found that beta-carotene supplementation increased colorectal adenoma recurrence risk among smokers and heavy drinkers. Randomized trials showed a significant decrease in adenoma recurrence risk without smoking or drinking, but paradoxical results when exposed to these lifestyle factors.
A new trial found that routine electronic fetal monitoring, known as admission cardiotocography, has no impact on infant death or moderate to severe illness rates. The practice may also increase the risk of unnecessary interventions during childbirth.
A focused microwave heat therapy technique shows promise in killing tumor cells before surgery and radiation, with a majority of patients experiencing significant tumor kill. The technology was invented by MIT researchers and is being developed into a clinical thermotherapy system by Celsion Corporation.
A randomized multicenter trial of 840 patients with severe heart attacks found no difference in mortality between pre-hospital fibrinolysis and emergency angioplasty. Despite this, experts advocate for early intervention with antiplatelet therapy and primary PTCA, regardless of hospital proximity.
A recent study of over 1,350 men found no correlation between a low-fat, high-fiber diet and reduced PSA levels over a four-year period. The study suggests that a healthy dietary pattern may still have an inhibitory effect on prostate cancer incidence despite the lack of impact on PSA levels.
A randomized controlled trial found that early laser treatment of uncomplicated childhood haemangiomas offered no significant benefits in terms of clearance or cosmetic concerns. However, treated lesions were at a higher risk of skin atrophy and hypopigmentation compared to untreated children.
Researchers found no difference in cosmetic appearance between sutured and non-sutured hand cuts after three months. Patients treated conservatively reported less pain and shorter treatment times compared to those who received sutures.
The USPSTF recommends screening all adults for depression, as five percent to nine percent of adult patients in primary care settings suffer from the condition. Depression can be treated with counseling, medications, or both, reducing health care utilization and costs associated with lost workdays.
A large randomized controlled study of e-mail communication between physicians and patients found that messages from patients were appropriate and needed by doctors. Patients sent an average of 49 messages per 100 scheduled visits, but the sharp increase didn't lead to a corresponding drop in calls or no-shows.
Chronic heart failure affects 5 million US people, with poor hospital outcomes and high readmission rates. Researchers conducted large placebo-controlled trials to develop treatment guidelines for this condition.
A study found that two forms of bias in cause-of-death classification affect the results of randomized trials on cancer screening. Sticky-diagnosis bias biases against screening, while slippery-linkage bias biases in favor of screening. The authors suggest using all-cause mortality to accurately assess the value of screening.
The ACCESS study confirms that Atacand improves outcomes for patients with acute ischaemic stroke and high blood pressure. Early treatment with Atacand reduces the risk of total mortality, cerebral complications, and cardiovascular complications by 47.5 percent.
A recent randomized controlled trial suggests that preventing falls among elderly people remains a challenging task. Despite improvements in adherence to interventions, injuries and subsequent harm persist. Researchers emphasize the need for continued research and practice to address this critical public health issue.
A review of patients treated with NIPPV found mortality rates were 28.6% higher in the clinical setting compared to randomized trials. The authors recommend developing practice guidelines to optimize NIPPV use. Dr. Sheldon Magder comments on the limitations of relying heavily on randomized trial findings in clinical settings.
A randomized clinical trial showed that combining bone marrow transplant and high-dose chemoradiotherapy significantly improves disease-free survival in children with neuroblastoma. The addition of vitamin A-derivative treatment further increases survival rates by nearly three-fold.